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Caged intracellular NMDA receptor blockers
for the study of subcellular ion channel function
James E. Reeve,1 Michael M. Kohl,2 Antonio Rodríguez-Moreno,2,3 Ole Paulsen2,* and Harry L. Anderson1,*
1Department of Chemistry; University of Oxford; Oxford, UK; 2Department of Physiology, Development and Neuroscience; University of Cambridge; Cambridge, UK;
3Department of Physiology, Anatomy and Cellular Biology; University Pablo de Olavide; Seville, Spain
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We have previously synthesized a caged form of the use-dependent N-methyl-D-aspartate (NMDA) receptor ion channel
blocker MK801 and used intracellular photolysis of this compound to demonstrate the subcellular location of NMDA
receptor ion channels involved in synaptic plasticity. Here, we discuss considerations regarding the choice of caging
molecule, synthesis and the potential uses for caged ion channel blockers in neurophysiology.
Introduction
Pharmacological interventions are a valuable tool for the dissec-
tion of biological functions. In the study of excitable cells, such as
neurons, drugs that block ion channels are of particular use. In
acute brain slices, drug effects are commonly restricted to three
levels: (1), the whole tissue preparation through addition of the
drug to the incubation medium; (2), a small volume of tissue
through local pressure injection or microiontophoresis; (3), a
single cell through addition of the drug to the whole-cell patch-
clamp pipette. Through photolysis of a novel caged NMDA
receptor antagonist, added via a patch pipette, we recently
demonstrated control of ion channel activity at the subcellular
level1 (Fig. 1). This is of particular interest when studying the
localization of ion channel function in highly compartmentalised
cells such as neurons.
Cage Choice Considerations
A number of photolabile compounds have been used in the
past to achieve improved spatial and temporal control of free
calcium, neurotransmitters, intracellular signaling molecules and
ion channel blockers (for review, see ref. 2). We based our design
on the nitrophenyl-based photolabile protecting group (cage)
nitroveratryloxycarbonyl (NVOC) rather than other commonly
employed cages such as methoxy nitroindolinyl (MNI)3 or
nitrophenyl ethyl (NPE)4 since it could be easily derivatised at
its phenolic positions. Due to the relatively low uncaging
efficiency of the NVOC group, it may be handled under ambient
light conditions and excellent contrast can be achieved between
subcellular compartments. NVOC cages are neuropharmocologi-
cally compatible; we showed that the cage itself does not cause
any channel blocking, unlike MNI which interacts with GABAA
receptors.5 We synthesized both NVOC-protected MK801
(cMK801, Fig. 2A) and a novel triethylene glycol-substituted
nitrophenyl cage-protected MK801 (TcMK801, Fig. 2B).
Formulation of cMK801 with Polysorbate 20 afforded sufficient
water-solubility, though was detrimental to quick patch-clamp
seal formation. Water solubility conferred instead by the triethy-
lene glycol chains of TcMK801 permitted a formulation-free
solution of caged MK801, which permits seal formation, as with
standard aqueous intracellular solutions.
Compound Synthesis and Improvement
of Water-Solubility
4,5-Bis{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}-2-nitrobenzalde-
hyde. This compound was prepared according to an adapted
literature procedure.6 A solution of 4,5-dihydroxy-2-nitrobenzal-
dehyde (60 mg, 327 mmol), 2-[2-(2-methoxyethoxy)ethoxy]ethyl
tosylate (209 mg, 655 mmol) and K2CO3 (90 mg, 655 mmol) in
anhydrous acetonitrile (5 mL) was refluxed for 16 h under N2.
The mixture was evaporated to dryness and purified by flash
chromatography (ethyl acetate). The combined fractions were
evaporated to dryness to yield 1 as a yellow oil (92 mg, 59%). 1H
NMR (400 MHz, CDCl3) dH 10.43 (s, 1H), 7.71 (s, 1H), 7.45
(s, 1H), 4.32 (m, 4H), 3.94 (m, 4H), 3.75 (s, 4H), 3.66 (m, 8H),
3.55 (m, 4H), 3.38 (s, 6H). 13C NMR (100 MHz, CDCl3) dC
188.16, 153.39, 152.23, 144.19, 125.99, 111.87, 109.61, 72.35,
71.43, 71.13, 71.03, 69.91, 69.71, 59.48. m/z (ESI+) 498.18
([M+Na]+ 100%, C21H33ClNNaO11+ requires 498.20).
|4,5-Bis{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}-2-nitrophe-
nyl|methanol. This compound was prepared according to an
adapted literature procedure.6 NaBH4 (18.5 mg, 490mmol) was
added portionwise to a solution of 4,5-bis{2-[2-(2-methoxyethoxy)
ethoxy]ethoxy}-2-nitrobenzaldehyde 1 (46.6 mg, 98 mmol) in
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anhydrous methanol (1.5mL) at 5°C. The reaction mixture was
allowed to warm to room temperature and stirred for 3 h. The
reaction was quenched with HCl(aq) (5mL, 1.0M) and extracted
with chloroform (310mL). The combined organic layers were
washed with saturated NaCl solution (5mL) and evaporated to
dryness to yield 2 as a colorless oil (30mg, 64%). 1H NMR
(400MHz, CDCl3) dH 7.76 (s, 1H), 7.35 (s, 1H), 4.95 (s, 2H),
4.33 (m, 2H), 4.23 (m, 2H), 3.90 (m, 4H), 3.74 (m, 4H), 3.66 (m,
8H), 3.55 (m, 4H), 3.37 (s, 3H), 3.36 (s, 3H), 1.25 (s, 1H). 13C
NMR (100 MHz, CDCl3) dC 153.86, 147.25, 139.44, 133.19,
112.74, 110.56, 71.90, 71.87, 70.90, 70.79, 70.69, 70.65, 70.55,
70.43, 69.78, 69.51, 69.14, 68.89, 62.50, 59.01. m/z (ESI+)
500.16 [(M+Na)+ 100%, C21H35NNaO11+ requires 500.21].
4,5-Bis{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}-2-nitrobenzyl
chloroformate. A mixture of |4,5-bis{2-[2-(2-methoxyethoxy)
ethoxy]ethoxy}-2-nitrophenyl|methanol 2 (30mg, 63 mmol) and
triphosgene (28mg, 94.5 mmol) in chloroform (5 mL) was stirred
for 2 h. Further triphosgene (18mg, 63 mmol) was added and
the mixture stirred for 30 min. When the reaction was com-
plete by thin layer chromatography (TLC), the mixture was
evaporated to dryness and purified by column chromatography
on SiO2 (1% MeOH in ethyl acetate). Combined fractions
were evaporated and dried in vacuo to yield the product 3 as a
colorless oil (20 mg, 59%). 1H NMR (400 MHz, CDCl3) dH
7.83 (s, 1H), 7.06 (s, 1H), 5.70 (s, 2H), 4.26 (m, 4H), 3.93
(m, 4H), 3.73 (m, 4H), 3.67 (m, 8H), 3.57 (m, 4H), 3.38
(s, 6H). m/z (ESI+) 562.18 [(M+Na)+ 100%, C22H34ClNNaO12+
requires 562.16]
TcMK801. This compound was prepared according to an
adapted literature procedure.7 A solution of 4,5-bis{2-[2-(2-
methoxyethoxy)ethoxy]ethoxy}-2-nitrobenzyl chloroformate 3
(20mg, 37 mmol) in tetrahydrofuran (THF, 0.5 mL) was added
to a solution of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]
cyclohepten-5,10-imine maleate (MK801, 12.4mg, 37 mmol),
Na2CO3 monohydrate (18.4mg, 148 mmol) and dioxane
(0.5mL) in water (1.0mL). The mixture was stirred for 48 h.
The reaction mixture was poured onto saturated Na2CO3(aq)
(2 mL), extracted with chloroform (2  5 mL) and washed with
water (2  5 mL). The organic layer was evaporated to dryness
and purified by column chromatography on SiO2 (1% MeOH
in ethyl acetate). Combined fractions were evaporated and dried
in vacuo to yield the product 4 as a colorless oil (8 mg, 29%).
1H NMR (400 MHz, CDCl3) dH 7.75 (m, 1H), 7.33 (m, 1H),
7.31 (m, 2H), 7.19 (m, 2H), 7.10 (m, 2H), 7.08 (m, 1H), 6.92
(m, 1H), 5.51 (s, 1H), 5.49 (s, 1H), 4.22 (m, 2H), 3.88 (m, 2H),
3.82 (m, 4H), 3.74 (m, 4H), 3.65 (m, 8H), 3.55 (m, 4H), 3.38
(s, 3H), 3.37 (s, 3H), 2.69 (d, J = 17.1Hz, 1H), 2.26 (s, 3H),
1.26 (s, 2H). 13C NMR (100MHz, CDCl3) dC 207.00, 167.75,
Figure 1. Spot photolysis of a caged ion-channel blocker with UV light
allows for precise temporal and spatial control of the drug effect.
Figure 2. (A) Nitroveratryloxycarbonyl-protected MK801 (cMK801). (B) Synthesis of TEG-substituted caged MK801 (TcMK801) from 4,5-dihydroxy-2-
nitrobenzaldehyde. (1) Triethylene glycol monomethyl monotosylate ether, K2CO3, MeCN, reflux, 16 h. (2) NaBH4, MeOH, rt, 3 h. (3) (Cl3CO)2CO, Et3N,
CHCl3, rt, 2.5 h. (4) Dizocilpine maleate (MK801), Na2CO3, dioxane, THF, water, rt, 48 h.
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153.33, 143.27, 139.16, 130.86, 130.44, 128.78, 127.64,
127.52, 127.41, 126.13, 121.28, 118.60, 110.79, 71.90,
70.91, 70.66, 70.54, 69.47, 69.21, 68.79, 67.95, 67.06, 59.86,
59.01, 38.70, 30.91, 30.33, 29.67, 28.89, 25.58, 23.72, 22.96,
22.67, 14.03, 10.94. m/z (ESI+) 747.3100 [(M+Na)+ 100%,
C38H48N2NaO12+ requires 747.3099].
Potential Uses
A wide variety of caging groups exists, making it possible to tailor
the photolysis of a caged compound to suit desired experimental
conditions. Judicious choice of caging group allows specification
of photolysis wavelength, temporal release behavior and light
sensitivity. Photolysis can be achieved with millisecond precision,
enabling the study of fast events like calcium8,9 and neurotrans-
mitter10-12 signaling and slower events such as the expression of
synaptic plasticity.1
The caged compounds cMK801 and TcMK0801 presented
here are effective under one-photon activation. Greater spatial
selectivity and depth penetration may be achieved by two-photon
excitation due to the reduction in scattering and excitation out of
the focal plane. Advances in two-photon photolysis8 promise to
improve spatial resolution and allow the precisely defined
uncaging of compounds in volumes as small as 1 mm3. A two-
photon-optimized caged potassium channel blocker is commer-
cially available13 and we are directing efforts toward preparing
two-photon-optimized variants of our caged NMDA receptor
channel blocker. Using these compounds to selectively block
neuronal conductances via two-photon photolysis will enable
the dissection of neuronal signal integration in dendritic sub-
compartments. This approach can be extended to other phar-
macologically active substances, allowing the study of cellular
function and signaling at unprecedented levels of detail.
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